Vorinostat in Treating Patients With Metastatic Melanoma of the Eye
Clinical trial NCT01587352 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT01587352
- Sponsor
- National Cancer Institute (NCI)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-05-29
- Primary completion
- 2026-12-31
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.